Research Article

A Novel Herbal Medicine for Dyslipidemia: Assessments in Experimental Models

Table 2

Effect of GANMO on lipid levels in cholesterol-induced dyslipidemia after 2 weeks of treatment.

Groups/treatment 2nd weeknTG ( ± SD)TC ( ± SD)HDL-C ( ± SD)LDL-C ( ± SD)

Control group100.50 ± 0.112.16 ± 0.151.08 ± 0.150.85 ± 0.22
Model group100.54 ± 0.172.38 ± 0.351.16 ± 0.201.11 ± 0.19
Atorvastatin (10 mg/kg)100.49 ± 0.122.36 ± 0.291.06 ± 0.161.08 ± 0.34
GANMO (15.1 g/kg)100.74 ± 0.252.66 ± 0.281.05 ± 0.221.27 ± 0.46
GANMO (45.3 g/kg)100.45 ± 0.142.56 ± 0.330.99 ± 0.171.37 ± 0.40